CAPABILITIES
Delivering Trust, One Prescription at a Time Over 400 scientifically backed formulations in acute and chronic therapies.
R&D
Overview
Key Divisions
Capabilities Include
Download DCGI Approved Molecules
Innovation That Enriches Lives
Our Research & Development (R&D) center at Synokem Lifesciences (Plant 3) is designed with the latest technology and improved lab infrastructure to support quality pharma R&D, formulation development, and prototype validation. We have the capability for new product development with smooth transfer of technology through our expert Formulation & Development (F&D) team for successful transition from development to mass production. It is our Analytical Development Laboratory (ADL) that is committed to developing and qualifying advanced analytical methodologies that yield sensitive, precise, and accurate data with minimal turnaround time. We develop robust test protocols for assay, content uniformity, dissolution, related substances, residual solvents, and other in-house quality analyses. Each analysis step is thoroughly performed to global pharma standards to appropriately assess critical quality attributes, thereby delivering safe, effective, and consistent medicines to patients around the world.